Innamaa, A <br/><br/>
Expression and effects of modulation of the K2P potassium channels TREK-1 (KCNK2) and TREK-2 (KCNK10) in the normal human ovary and epithelial ovarian cancer.  [electronic resource] 

 -  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico  Nov 2013 
 - 910-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1699-3055 
<br/><br/><label>Standard No.: </label>10.1007/s12094-013-1022-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma, Clear Cell--drug therapy<br/>Adenocarcinoma, Mucinous--drug therapy<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Biomarkers, Tumor--metabolism<br/>Blotting, Western<br/>Case-Control Studies<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Curcumin--pharmacology<br/>Cystadenocarcinoma, Serous--drug therapy<br/>Endometrial Neoplasms--drug therapy<br/>Female<br/>Flow Cytometry<br/>Fluorescent Antibody Technique<br/>Follow-Up Studies<br/>Humans<br/>Immunoenzyme Techniques<br/>Male<br/>Middle Aged<br/>Neoplasm Grading<br/>Ovarian Neoplasms--drug therapy<br/>Ovary--drug effects<br/>Potassium Channels, Tandem Pore Domain--metabolism<br/>Prognosis<br/>Survival Rate